Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A simple dose tweak could keep hair loss treatment on track. A new study found that tapering finasteride resolved sexual side effects in 75% of men — without requiring them to quit the medication entirely. Reducing from 1 mg to 0.5 mg daily was the key move, and for those who couldn't tolerate even the lowest oral dose, switching to topical finasteride eliminated side effects altogether.
For men battling male pattern hair loss, finasteride is a go-to treatment — but sexual side effects can be a dealbreaker. A new retrospective study out of Australia offers a practical workaround: simply tapering the dose. Among 100 men who developed sexual side effects on finasteride, 75% saw their symptoms resolve after dose tapering, allowing them to stay on treatment.
The most common side effect was reduced libido (83%), followed by erectile dysfunction (35%) and ejaculatory dysfunction (6%). Side effects typically appeared around 42 weeks into treatment. While discontinuation had the highest resolution rate (95.8%), tapering came close — and crucially, kept patients on therapy. For those who couldn't tolerate even the lowest oral dose, switching to topical finasteride (0.25–0.5%) eliminated side effects entirely over a mean follow-up of 28.4 weeks.
By the Numbers:
Why it matters: Sexual side effects are a leading reason men stop finasteride — often unnecessarily. This study suggests that a simple dose reduction, rather than full discontinuation, can resolve symptoms in most patients while preserving treatment benefits for hair loss.
